The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)-a sector of the government agency that aims to incentivize innovation among providers and payers.
The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)—a sector of the government agency that aims to incentivize innovation among providers and payers.
States across the country have benefited from CMMI’s 10-year, $10 billion budget. In fact, it is the largest sum of funding ever devoted to healthcare transformation. The center intends to accelerate the development and testing of new payment and service delivery models at various healthcare organizations. The center’s supported innovation models are divided into 7 categories:
The group also encourages healthcare organizations and leaders to offer their own ideas about innovations. The center says it seeks input on innovative service delivery models, reimbursement models, and even technology.
“We look for ideas across the healthcare delivery continuum that achieve better care for patients, better health for our communities, and lower costs through improvement for our healthcare system,” the center said.
Still, not everyone is completely convinced that the group is fulfilling its purpose. “This is absolutely necessary” to try to change how care is bought and delivered, said Christopher Koller, president of the Milbank Memorial Fund, a nonprofit that works to improve medical decision making. “Is this the right way to do it? A whole bunch of experiments? Is the innovation center adequately resourced in an administrative way to do this? The jury is still out on this.”
CMMI programs focus on patient populations with expensive conditions including cancer, diabetes, and heart failure. Groups who opt into CMMI innovation programs must demonstrate quality improvements within 6 months of enrollment. Center officials maintain that the group has an important role in improving patients’ health and controlling the rising costs of healthcare throughout the country.
“We take the direction of Congress—that the goal was to test these models, to expand the successful ones, but also to terminate unsuccessful ones—very seriously,” said Patrick Conway, MD, who runs the center.
Around the Web
CMS is on a $10B Search for the Next Big Health Insurance Innovation — But Is It Going Anywhere? [MedCity News]
Innovation Models [CMS - CMMI]
New Blueprint Guides Patient-Centered Research for More Equitable Health Care
July 17th 2025The new Blueprint for Patient-Centered Value Research offers a roadmap for embedding patient voices throughout every stage of the research journey to foster more equitable, transparent, and responsive health care systems.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More